| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |